Cook Biotech Incorporated, a world leader in regenerative medicine, was established in 1995 to develop and manufacture biologic tissue grafts utilizing extracellular matrix technology (ECM). Cook Biotech products have been used in more than 1.5 million soft-tissue-repair treatments worldwide, including treatment for fistula, hernia and pelvic organ prolapse.
A complex, natural scaffold makes Cook’s products work. If given the right environment, the human body has an amazing capacity to heal itself. Cook’s products support cell growth into, around and through the ECM implants until the tissue is regenerated. The tissue is repaired, without a foreign material left behind.
Applications for this technology are continually increasing, and Cook Biotech is dedicated to working closely with clinicians, hospitals, patients and corporate partners to provide the most advanced tissue-growth technology.
Stay up to date on our latest news, breakthroughs, and other announcements.
